中医临床研究
中醫臨床研究
중의림상연구
CLINICAL JOURNAL OF CHINESE MEDICINE
2013年
24期
60-62
,共3页
儿童支气管哮喘%急性发作期%中药%氟卡替松%肺功能
兒童支氣管哮喘%急性髮作期%中藥%氟卡替鬆%肺功能
인동지기관효천%급성발작기%중약%불잡체송%폐공능
Children bronchial asthma%Acute phase%TCM%Fluorine card for loose%Lung functio
目的：观察自拟柴防平喘汤结合西药丙酸氟卡替松吸入气雾剂治疗急性发作期小儿哮喘的临床疗效。方法：将于急性发作期支气管哮患儿80例随机分为治疗组与对照组，各40例。两组均予以常规对症治疗，对照组予丙酸氟卡替松吸入气雾剂，治疗组在对照组治疗基础上加用柴防平喘汤。两组均治疗7d。观察比较两组患儿主要临床症状消失时间、治疗前后肺功能、临床疗效。结果：治疗组患儿咳嗽、喘息、咯痰、肺部啰音消失时间均优于对照组（P<0.05）。治疗后肺功能比较，治疗组优于对照组（P<0.05）。对照组总有效率87.5%，治疗组总有效率100.0%，两组比较，差异有统计学意义（P<0.05）。结论：自拟柴防平喘汤结合西药丙酸氟卡替松吸入气雾剂治疗急性发作期小儿哮喘疗效显著优于单用西药，且安全性良好，值得进一步推广、研究。
目的：觀察自擬柴防平喘湯結閤西藥丙痠氟卡替鬆吸入氣霧劑治療急性髮作期小兒哮喘的臨床療效。方法：將于急性髮作期支氣管哮患兒80例隨機分為治療組與對照組，各40例。兩組均予以常規對癥治療，對照組予丙痠氟卡替鬆吸入氣霧劑，治療組在對照組治療基礎上加用柴防平喘湯。兩組均治療7d。觀察比較兩組患兒主要臨床癥狀消失時間、治療前後肺功能、臨床療效。結果：治療組患兒咳嗽、喘息、咯痰、肺部啰音消失時間均優于對照組（P<0.05）。治療後肺功能比較，治療組優于對照組（P<0.05）。對照組總有效率87.5%，治療組總有效率100.0%，兩組比較，差異有統計學意義（P<0.05）。結論：自擬柴防平喘湯結閤西藥丙痠氟卡替鬆吸入氣霧劑治療急性髮作期小兒哮喘療效顯著優于單用西藥，且安全性良好，值得進一步推廣、研究。
목적：관찰자의시방평천탕결합서약병산불잡체송흡입기무제치료급성발작기소인효천적림상료효。방법：장우급성발작기지기관효환인80례수궤분위치료조여대조조，각40례。량조균여이상규대증치료，대조조여병산불잡체송흡입기무제，치료조재대조조치료기출상가용시방평천탕。량조균치료7d。관찰비교량조환인주요림상증상소실시간、치료전후폐공능、림상료효。결과：치료조환인해수、천식、각담、폐부라음소실시간균우우대조조（P<0.05）。치료후폐공능비교，치료조우우대조조（P<0.05）。대조조총유효솔87.5%，치료조총유효솔100.0%，량조비교，차이유통계학의의（P<0.05）。결론：자의시방평천탕결합서약병산불잡체송흡입기무제치료급성발작기소인효천료효현저우우단용서약，차안전성량호，치득진일보추엄、연구。
Objective:To study the clinical efficacy of the Chaifang Pingchuan decoction combined with fluticasone propionate inhalation aerosol. Methods:80 cases were randomly divided into the treated group and control group, 40 cases in each. The two group were given conventional symptomatic treatment, the control group with fluticasone propionate card for inhaled aerosol, the treated group add the Chaifang Pingchuan decoction based on the treatment of the control group. Two groups were treated for 7 days. Compared two groups of children with major clinical symptoms disappear time, pulmonary function before and after the treatment, the clinical curative effect. Results:The treated group with cough, wheeze, cough up phlegm, and lung then disappear time were better (P<0.05). Lung function after treatment, the treated group was better than that of control group (P<0.05). The total efficiency of the control group was 87.5%, and was 100.0% of the treated group, two groups of comparison, the difference was statistically significant (P<0.05). Conclusion: The ingegrative medicine is effective on treating acute episode of bronchial asthma in children, and security is good, worthy of further promotion and research.
